Recombinant Human HDAC3 Protein，His

Histone deacetylase 3 (HDAC3) is a critical enzyme involved in the regulation of gene expression through chromatin remodeling, impacting various cellular processes such as development, differentiation, and cell cycle progression. HDAC3 operates as part of several multiprotein complexes, influencing the acetylation status of histones and non-histone proteins, thus altering transcriptional activity. Aberrant expression or activity of HDAC3 has been implicated in a variety of diseases, particularly cancer, where it can contribute to the silencing of tumor suppressor genes and the promotion of oncogenic pathways. Consequently, understanding the structural and functional properties of HDAC3 is crucial for developing targeted therapies. Researchers have focused on recombinant expression systems to produce HDAC3 proteins for biochemical and structural studies, enabling the exploration of its catalytic mechanisms, inhibition strategies, and interactions with other cellular factors. Recent advancements in crystallography and cryo-electron microscopy have provided insights into the enzyme's three-dimensional structure, facilitating the design of small-molecule inhibitors with potential therapeutic applications. The ongoing investigation of HDAC3's role in epigenetic regulation also highlights its importance as a therapeutic target in cancer treatment and other diseases associated with dysregulated gene expression. As our understanding of HDAC3 continues to grow, it holds promise for novel strategies in precision medicine, making it a focal point of contemporary biomedical research.